Expression of von willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas Christophe Poncelet, M.D., Patrick Madelenat, M.D., Gérard Feldmann, M.D., Ph.D., Francine Walker, M.D., Ph.D., Emile Darai, M.D., Ph.D. Fertility and Sterility Volume 78, Issue 3, Pages 581-586 (September 2002) DOI: 10.1016/S0015-0282(02)03301-0
FIGURE 1 Microvessel immunostaining (arrows) using von Willebrand’s factor in (A) leiomyomas and (C) myometrium. Microvessel immunostaining (arrows) using CD34 in (B) leiomyomas and (D) myometrium. (Counterstaining, hematoxylin; magnification ×400.) Poncelet. Angiogenesis in uterine leiomyomas. Fertil Steril 2002. Fertility and Sterility 2002 78, 581-586DOI: (10.1016/S0015-0282(02)03301-0)